CareCloud Achieves First Full-Year GAAP Profitability, Reports Revenue Growth and Strategic Acquisitions
summarizeSummary
CareCloud, Inc. reported its first full-year positive GAAP EPS since its IPO, alongside revenue and Adjusted EBITDA growth, driven by strategic acquisitions and a significant capital structure restructuring involving preferred stock conversion.
check_boxKey Events
-
Achieved First Full-Year Positive GAAP EPS Since IPO
CareCloud reported net income of $10.798 million and basic EPS of $0.10 for the year ended December 31, 2025, a significant improvement from a net loss in 2024.
-
Strong Revenue and Adjusted EBITDA Growth
Net revenue increased 9% to $120.499 million, and Adjusted EBITDA grew to $27.549 million in 2025, demonstrating improved operational performance.
-
Significant Capital Structure Restructuring
In March 2025, 3,541,701 shares of Series A Preferred Stock were converted into 25,981,248 common shares, addressing accumulated dividends but causing substantial dilution for common shareholders.
-
Increased Common Share Authorization
Shareholders approved an increase in authorized common shares from 35 million to 85 million in January 2025. If all authorized shares were issued, dilution would be 100.03%.
auto_awesomeAnalysis
CareCloud, Inc. has reported its first full year of positive GAAP EPS since its IPO, marking a significant financial turnaround. The company demonstrated solid revenue and Adjusted EBITDA growth, indicating improved operational performance. A major capital restructuring involved converting a substantial portion of Series A Preferred Stock into common shares, which, while addressing accumulated dividends and simplifying the capital structure, resulted in significant dilution for common shareholders. The increase in authorized common shares provides considerable flexibility for future equity raises. Additionally, CareCloud pursued an active acquisition strategy in 2025, integrating three new businesses to expand its market presence and service offerings. The resumption of preferred stock dividends and a plan to accelerate payments for Series B arrears signal a commitment to preferred shareholders. Investors should weigh the positive financial performance and strategic growth initiatives against the substantial dilution from the preferred stock conversion and the high potential for future dilution if all authorized shares are issued.
At the time of this filing, CCLD was trading at $2.91 on NASDAQ in the Technology sector, with a market capitalization of approximately $123.4M. The 52-week trading range was $1.14 to $4.01. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.